Global H1N1 Vaccine Market

What’s The Growth Forecast For H1N1 Vaccine Market Through 2023-2032?

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s H1N1 Vaccine Global Market Report 2023, The global H1N1 vaccine market is expected to grow from $2.94 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The H1N1 vaccine market size is expected to grow to $4.04 billion in 2027 at a CAGR of 6.5%.

What was the major driver in the H1N1 vaccine market?
Increased spending on research & development in immunology and vaccines is projected to drive the growth of the H1N1 vaccine market in the future. Immunology and vaccines are used to prevent diseases and aid in the production of antibodies. Immunology is a vital field of study in the medical and biological sciences that focuses on the immune system. The H1N1 vaccine is a formulation used to stimulate antibody synthesis, resulting in immunisation against a number of infections. According to an article published by the kENUP Foundation, a Europe-based non-profit that supports research-based innovation in the health industry, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic in January 2021. In just 11 months, the public sector dedicated 95% of total spending, or $87.54 billion (€86.5 billion), to vaccine development. As a result, rising investment in research & development in immunology and vaccines is propelling the H1N1 vaccine market forward.

View More On The H1N1 Vaccine Market Report 2023 –

What was the key trend in the H1N1 vaccine market?
Strategic company alliances are a significant trend that is gaining traction in the H1N1 (swine flu) vaccination market. Strategic alliances are being pursued by companies in the H1N1 (swine flu) Vaccination industry in order to increase their market share. For example, in August 2022, A significant, a pharmaceutical company, and Open Orphan affiliate hVIVO agreed to a $123 million agreement to develop a brand-new batch of H1N1 influenza challenge virus. This has boosted the prospective growth of both companies in the market.

Which was the largest region in the H1N1 vaccine market?
North America was the largest region in the H1N1 vaccine market in 2022. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Who are the H1N1 vaccine market prominent players?
Major players in the H1N1 vaccine market are Sanofi, Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca, Zydus Cadila, Merck and Co. Inc., NovavaxInc., Baxter, Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation., Seqirus, and Cipla Inc.

Key H1N1 vaccine market segments
The global H1N1 vaccine market is segmented –
1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination
3) By End Users: Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users

Request A Sample Of The Global H1N1 Vaccine Market Report 2023:

The H1N1 Vaccine Global Market Report 2023  provides a comprehensive overview on the H1N1 vaccine market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
DTP Vaccines Global Market Report 2023
Veterinary Vaccines Global Market Report 2023
Vaccine Adjuvants Global Market Report 2023

Contact us at:
The Business Research Company:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on: 
Global Market Model: